Skip to main content
Vertex Pharmaceuticals Incorporated (ETR:VX1)
Germany flag Germany · Delayed Price · Currency is EUR
452.70
-7.90 (-1.72%)
Mar 31, 2025, 2:20 PM CET

Vertex Pharmaceuticals Revenue

In the year 2024, Vertex Pharmaceuticals had annual revenue of $11.02B USD with 11.66% growth. Vertex Pharmaceuticals had revenue of $2.91B in the quarter ending December 31, 2024, with 15.66% growth.

Revenue
$11.02B
Revenue Growth
+11.66%
P/S Ratio
n/a
Revenue / Employee
$1.81M
Employees
6,100
Market Cap
116.80B EUR

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202411.02B1.15B11.66%
Dec 31, 20239.87B938.50M10.51%
Dec 31, 20228.93B1.36B17.91%
Dec 31, 20217.57B1.37B22.06%
Dec 31, 20206.21B2.04B49.08%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Merck KGaA 21.16B
Siemens Healthineers AG 22.67B
Fresenius SE & Co. KGaA 21.83B
Bayer Aktiengesellschaft 46.61B
Sartorius Aktiengesellschaft 3.38B
Fresenius Medical Care AG 19.34B
Carl Zeiss Meditec AG 2.08B
Fielmann Group AG 2.16B
Revenue Rankings

Vertex Pharmaceuticals News

More News